VisiRose (NASDAQ:PVCT) | Finanzwire

Basculer en Français

10097	Companies
206690	Keywords
136846	Articles
109548	Press releases

Home
Companies
VisiRose

BRIEF

published on 12/10/2024 at 13:35, 1 year 3 months ago

VisiRose Launches Innovative Eye Infection Therapy RB PDAT

Biotechnology Antimicrobial Resistance VisiRose RB PDAT Eye Infections
PRESS RELEASE

published on 12/10/2024 at 13:30, 1 year 3 months ago

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
VisiRose, a clinical-stage biotechnology company, collaborates with Bascom Palmer Eye Institute to introduce Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT) for eye infections. The innovative treatment addresses antimicrobial resistance and offers hope for patients worldwide

Innovative Treatment VisiRose RB PDAT Eye Infections Bascom Palmer Eye Institute

Accesswire

Published on 03/26/2026 at 11:07, 20 minutes ago

U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 27 minutes ago

Pivotree Announces Fourth Quarter 2025 Results
Published on 03/26/2026 at 11:00, 27 minutes ago

Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 22 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 32 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 11:03, 24 minutes ago

EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 26 minutes ago

Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 27 minutes ago

Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 27 minutes ago

ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 27 minutes ago

Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months

Les Echos

Published on 03/26/2026 at 08:57, 2 hours 29 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 3 hours 57 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 16 hours 33 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 16 hours 56 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 42 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE